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The insertion of tail-anchored transmembrane (TA) proteins
into the appropriatemembrane is a post-translational event that
requires stabilization of the transmembrane domain and target-
ing to the proper destination. Sgt2 is a heat-shock protein cog-
nate (HSC) co-chaperone that preferentially binds endoplasmic
reticulum-destined TA proteins and directs them to the GET
pathway via Get4 and Get5. Here, we present the crystal struc-
ture from a fungal Sgt2 homolog of the tetratrico-repeat (TPR)
domain and part of the linker that connects to the C-terminal
domain. The linker extends into the two-carboxylate clamp of
the TPR domain from a symmetry-related molecule mimicking
the binding to HSCs. Based on this structure, we provide bio-
chemical evidence that the Sgt2 TPR domain has the ability to
directly bind multiple HSC family members. The structure
allows us to propose features involved in this lower specificity
relative to other TPR containing co-chaperones. We further
show that a dimer of Sgt2 binds a singleGet5 anduse small angle
x-ray scattering to characterize the domain arrangement of Sgt2
in solution. These results allow us to present a structural model
of the Sgt2-Get4/Get5-HSC complex.
The eukaryotic cell is a complex environment of multiple
membrane-bound organelles, eachwith a unique set of resident
integral membrane proteins. Biogenesis of these proteins
requires mechanisms for targeting and insertion into the cor-
rect membrane. For the majority destined to the ER2 mem-
brane, this is accomplished via the signal recognition particle
pathway (1).Major exceptions to this rule are tail-anchor trans-
membrane (TA) proteins that are defined topologically by a
single transmembrane helix within 30 residues of the C termi-
nus. Examples are found in all membranes exposed to the cyto-
plasm (2, 3). A dedicated targeting pathway for ER-destined TA
proteins has been elucidated and is called the GET pathway
(Guided Entry of TA proteins) in yeast (4). The central player is
Get3, a cytosolic ATPase that sequesters the transmembrane
segment of a newly synthesized TA protein for targeting. A
multiprotein complex consisting of Get4/Get5 and Sgt2 loads
the TA protein onto Get3 (5). Get4 is an -helical repeat pro-
tein that forms an obligate dimer with the N-terminal domain
of Get5 (6–8), which also contains a ubiquitin-like domain and
a C-terminal dimerization domain (6).
Sgt2, the small glutamine-rich tetratrico-repeat (TPR) con-
taining protein (SGT in mammals), is a 38-kDa protein highly
conserved across eukaryotes (9). It consists of an N-terminal
homo-dimerization domain, a TPR domain composed of three
TPR repeats, and a C-terminal domain that is rich in glutamine
andmethionine (10–12). The Sgt2 dimer has a larger hydrody-
namic radius than expected for a globular protein suggesting an
extended conformation (11, 12). SGT interacts with a variety of
proteins, notably heat-shock proteins and their cognates
(referred to here in general as HSC) such as Hsc70 and Hsp90,
which bind directly to theTPRdomain (11–14). SGTbinding to
HSCs appears to modulate the chaperone ATPase activity and
folding rates dependent on other HSC co-chaperones. Binding
to Hsc70 decreases ATPase activity and protein folding rates,
whereas a neuronal Hsc70 complex, including SGT and cys-
teine string protein, stimulates ATPase activity (13, 15, 16).
SGT also binds a number of viral proteins, and, in one case, the
interaction was mediated by the TPR domain (17–19). The
C-terminal domain of SGT is capable of binding hydrophobic
regions of protein, such as the N-terminal signal sequence of
myostatin and in vitro translated type 1 glucose transporter (11,
20).
The initial links between Sgt2 andGet5were fromproteome-
wide yeast two-hybrid and tandem-affinity purification assays
(21, 22). Additional yeast two-hybrid and pulldown assays dem-
onstrated that an N-terminal construct of Sgt2 was necessary
and sufficient for binding toGet5, and consequently Get4, in an
interaction also dependent upon the Ubl domain of Get5 (7,
14). A direct role for Sgt2 in the TA targeting pathway was
shownby two independent genetic interaction analyses indicat-
ing a strong functional connection with other GET pathway
members (23, 24). Both demonstrated TA proteinmis-localiza-
tion in Sgt2 deletion strains, and Battle et al. (23) proposed that
Sgt2 acts functionally upstream of Get5 and the other GET
members. Most recently, it has been shown using an in vitro
translation system that Sgt2 can bind to ER-destined TA pro-
teins directly through the C-terminal hydrophobic-binding
domain. With the aid of Get4/Get5, the TA protein is then
transferred to Get3 (5). TA proteins destined to the mitochon-
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Supplemental Material can be found at:
dria do not bind Sgt2 directly but are bound to TPR domain-
associated chaperones.
TPR domains are defined by a variable number of two-helix,
34-residue motifs and frequently mediate protein-protein
interaction (25). A subclass acts as co-chaperones of HSCs by
regulating nucleotide hydrolysis cycles, physically linking mul-
tiple HSC families, and/or connecting protein-folding path-
ways with alternate pathways such as ubiquitination and deg-
radation (26). Examples are found in protein phosphatase 5,
Hsp organizing protein (HOP in human, Sti1 in yeast) and C
terminus of Hsc70 interacting protein (CHIP) (27–29). This
TPR subclass is composed of three repeats followed in sequence
by a C-terminal capping helix and recognizes the C-terminal
residues of the HSC, exemplified by IEEVD in Hsc70 and
MEEVD in Hsp90. Five conserved residues from the TPR
domain mediate this interaction forming a motif named the
two-carboxylate clamp, based on the recognition of the termi-
nal acidic residue and the main-chain carboxylate (27).
Here we report the crystal structure of the Sgt2 TPR domain
from the filamentous fungus Aspergillus fumigatus (AfSgt2). A
crystallographic contact generates a serendipitous interaction
that mimics the carboxyl sequence of many HSCs binding to a
TPR co-chaperone. Based on a structural analysis, we demon-
strate biochemically that the Sgt2 TPR domain in Saccharomy-
ces cerevisiae (Sgt2) can directly bind to at least four different
HSC families.We also test the potential stoichiometry between
Sgt2 andGet5 and characterize the structure of Sgt2 in solution,
allowing us to present a structural model for the higher order
complex between chaperones, Sgt2 and Get4/Get5.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification—Get4/Get5 was pre-
pared as previously described (6). Sgt2, Ssa1, Sse1, Hsc82, and
Hsp104 were amplified from genomic DNA isolated from S.
cerevisiae strain S288C (AfSgt2 from A. fumigatus strain 118,
ATCC) and ligated into pET33b-derived vectors that added
N-terminal hexahistidine tags separated by a tobacco etch virus
protease site. Truncations were prepared by usingQuikChange
mutagenesis (Stratagene). Except for the crystallography, all
experiments used Sgt2 and its variants from the S. cerevisiae
homolog.
Sgt2 variants were expressed in Escherichia coli
BL21(DE3)Star (Invitrogen). Cells were lysed by sonication,
and proteins were purified by nickel affinity chromatography
(Qiagen). Proteins were digested with tobacco etch virus pro-
tease for 3 h at room temperature, and uncut protein and pro-
tease were removed by incubation with nickel-nitrilotriacetic
acid-agarose beads. Proteins were further purified by size-ex-
clusion chromatography (SEC) using Superdex 200 or Super-
dex 75 (GEHealthcare) and concentrated to 10–20mg/ml in 20
mM Tris, 100 mM NaCl, 5 mM 2-mercaptoethanol, pH 8.0. The
molecular weight of the AfSgt2 truncation product was deter-
mined by LC/MS at the Protein/Peptide MicroAnalytical Lab-
oratory at Caltech.
Ssa1, Sse1, Hsc82, and Hsp104 were expressed in Roset-
ta(DE3) (Novagen), lysed by sonication in 50mMK-HEPES, 300
mM KCl, 20 mM imidazole, 5 mM 2-mercaptoethanol, and 0.1%
TritonX-100, pH 8.0 and purified by nickel affinity chromatog-
raphy. Proteins were dialyzed against a buffer containing 0.1
mM EDTA during cleavage by tobacco etch virus protease
and further purified by anion-exchange chromatography
(ResourceQ, GE Healthcare) and SEC. Proteins were concen-
trated to 10–20 mg/ml in 20 mM K-HEPES, 100 mM KCl, 5 mM
2-mercaptoethanol, pH 8.0.
PulldownAssays—Binding reactions betweenGet4/Get5 and
Sgt2 were performed in 50 l of a 10% slurry of nickel-nitrilo-
triacetic acid-agarose in a binding buffer of 20mMTris, 100mM
NaCl, 40 mM imidazole, pH 8.0. Per reaction, 8 M of each
protein was mixed for 10 min at room temperature. The resin
waswashed three timeswith 100l of binding buffer and eluted
with binding buffer supplemented with 20 mM EDTA. Reac-
tions between Ssa1, Sse1,Hsc82, andHsp104with the Sgt2TPR
domain were performed in 50 l of 20 mM K-HEPES, 100 mM
KCl, 20 mM imidazole, 5 mM MgCl2, 5 mM ADP, 5 mM 2-mer-
captoethanol, pH 7.5. 50 M His-TPR domain were incubated
with 5 M chaperone on ice for 2 h and then added to 5 l of
nickel-nitrilotriacetic acid-agarose. The resinwaswashed twice
with 100 l of binding buffer and eluted with binding buffer
with 300 mM imidazole.
SEC with MALLS—Complexes between Sgt2 and Get4/Get5
were formed in 20 mM Tris, 100 mM NaCl, 5 mM 2-mercapto-
ethanol, pH 7.0, and resolved by SEC using Superdex 200 or
Superdex 75. To generate saturated complexes, 3-fold stoichio-
metric excesses of the smaller protein were used. Complex
peaks were confirmed by SDS-PAGE, concentrated to 10
mg/ml, and separated on a Shodex KW-804 column with mul-
tiangle laser light scattering (MALLS) data collected by a
DAWN HELEOS and Optilab rEX detector. Data were pro-
cessed with ASTRA (Wyatt).
Crystallization—Crystallization screening was performed
using the sitting drop vapor-diffusion method with commer-
cially available screens (Hampton Research, Qiagen, Molecular
Dimensions Ltd.) set up by a Mosquito robot (TTP Labtech)
then incubated at room temperature. A proteolytic product of
AfSgt2 crystallized after 1 week as rectangular prisms against a
reservoir of 25% PEG 1500 and 0.1 M MES/malic acid/Tris
buffer, pH 4.0 (PACT Premier condition 37), with dimensions
of50 50 25 m. They were soaked in reservoir solution
with glycerol added to 10% for 15 min, surrounded with per-
fluoropolyether PFO-X175/08 (Hampton Research) and flash
frozen in liquid nitrogen.
Data Collection, Structure Solution, and Refinement—X-ray
diffraction data were collected on beam line 12-2 at the Stan-
ford Synchrotron Radiation Laboratory (SSRL) using a Pilatus
6M pixel array detector at 100 K. A complete dataset was col-
lected froma single crystal to 1.72-Å resolution.Datawere inte-
grated, scaled, and merged using MOSFLM (30) and SCALA
(31). Phases were determined by molecular replacement using
the crystal structure of human SGT (PDB ID 2VYI) as a search
model by PHASER (32), and the model was rebuilt using
RESOLVE (33). The model was refined using COOT (34) and
PHENIX (35). Secondary structure-matching rootmean square
deviation values were obtained using COOT. Solvent-accessi-
ble surface area between copies was calculated using PISA (36).
Structure figures were prepared using PyMOL (37).
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Small Angle X-ray Scattering—Samples were concentrated
to 25 mg/ml and filtered through 0.22-m membranes. Over-
night dialysis was performed against 50mMTris, 100mMNaCl,
5 mM 2-mercaptoethanol, pH 8.0. Dilutions to 1, 2, 5, and 10
mg/ml were made using the dialysate, and concentrations were
determined using an ND-1000 spectrophotometer (Nanodrop
Technologies) and theoretical extinction coefficients derived
from protein sequences.
Data were collected at SSRL beam line 4-2 using a Rayonix
MX225-HE detector, 1.13-Å wavelength x-rays, and a detector
distance of 2.5 m. For each concentration, 20 exposures of 1 s
were collected covering amomentum transfer range of 0.0055–
0.3709 Å1. Data were reduced, averaged, and buffer-sub-
tracted using MARPARSE (38). Extrapolation to infinite dilu-
tion and merging were performed with PRIMUS (39). Guiner
analysis was performed using AutoRG, and distance distribu-
tion functions were determined with GNOM (40). Ab initio
reconstructions were performed using software available in the
ATSAS package (41). Sgt2-N and Sgt2-N-TPR were recon-
structed with imposed 2-fold symmetry as an additional con-
straint on the data. Sgt2-N/Get5-Ubl was reconstructed with-
out imposed symmetry.
RESULTS
Crystal Structure of a Fungal Sgt2 TPR Domain—We ex-
pressed the TPR and C-terminal domains of the A. fumigatus
homolog of Sgt2 (AfSgt2), corresponding to residues 109–341,
in E. coli and purified it using nickel-nitrilotriacetic acid affinity
chromatography. There was an extensive range of proteolysis,
and two major species could be resolved by SEC (supplemental
Fig. S1). The smaller protein is a proteolytic product with a
molecular mass of 17,547 Da, consistent with the predicted
molecular mass of residues 109–267. This protein yielded
orthorhombic crystals in space group F222 that diffracted to a
maximum of 1.72-Å resolution. The crystal structure was
solved by molecular replacement using the human SGT -iso-
formTPRdomain (SGTA) (42) as a searchmodel. A single copy
of theTPRdomain (AfSgt2-TPR)was located in the asymmetric
unit (Fig. 1A). Electron density extending from the C-terminal
helix of the TPR domain could bemodeled as 21 residues of the
linker connecting to the C-terminal domain. Overall, unambig-
uous electron density throughout the entire chain allowed res-
idues 109–254 to bemodeled and refined to an Rfactor of 0.1675
and an Rfree of 0.2082. Complete crystallographic statistics are
shown in supplemental Table S1.
TheAfSgt2-TPR has 38% sequence identity and 60% similar-
ity to the SGTA TPR domain and shares an architecture con-
sisting of three TPR repeats comprised by helices 1–6 with a
“capping” helix, 7 (Fig. 1, A and E). Like other domains com-
posed of three TPR repeats, these seven helices are arranged in
a right-handed supercoil (25) resulting in a concave surface
lined by 1, 3, 5, and 7. The C rootmean square deviation
between the TPR domains of the SGTA and AfSgt2 is 1.2 Å.
Relative to the truncated SGTA construct, 7 is extended by
five residues, and the angle formed between 6 and 7 is
increased by10° (Fig. 1B). Unlike the SGTA crystal structure,
which lacks extensive intermolecular contacts, AfSgt2-TPR
forms a crystallographic dimer with a symmetry-related copy,
burying 2108 Å2 of solvent-accessible surface area (Fig. 1A,
inset). This interface is mediated by the 7 helices, which pack
head-to-tail against one another, and residues 240–254 of the
linker to the C-terminal domain, which bind into the TPR
groove of the opposite copy in an extended conformation. This
includes a well ordered interaction between two acidic side
chains (Glu-239 to Asp-194) outside the groove that is unlikely
to occur in vivo and may be stabilized by the low pH of
crystallization.
Fortuitously, the sequence of residues 240–247 in AfSgt2,
PPADDVDD, resembles the C-terminal residues of Hsp70 and
Hsp90 homologs, exemplified respectively in yeast by
PTVEEVD in Ssa1 and TEMEEVD in Hsc82. These sequences
are recognized by a variety of TPR domains containing a two-
carboxylate clamp that anchors the EEVD motif (27). Hsp70/
Hsp90 Organizing Protein (HOP) contains three TPR domains
designated TPR1, TPR2a, and TPR2b. TPR1 specifically binds
Hsc70, whereas TPR2a binds Hsp90, and the crystal structures
of these interactions have allowed an understanding of deter-
minants of substrate specificity in TPR domains (27, 43). The
main chain conformation of the C-terminal linker region of
AfSgt2 in our crystal structure is identical to that of the
GPTIEEVD peptide bound to HOP TPR1 (Fig. 1C). The two-
carboxylate clamp is composed of five highly conserved resi-
dues that make hydrogen bonds to the main chain of the EEVD
motif. In AfSgt2, Arg-187 (Arg-175; for clarity when referenc-
ing the structure A. fumigatus numbering will be used and S.
cerevisiae sequence numbering will be provided in parenthesis)
and Lys-183 (Arg-171) interact with the carbonyl of Asp-244
and Arg-187 (Arg-175) makes an additional contact to the car-
bonyl of Asp-243 (Fig. 1D). Asn-122 (Asn-110) extends from3
to form a hydrogen bond with Asn-153 (Asn-141) from 5, and
these two asparagines hydrogen bond with the amide and car-
bonyl of Asp-246. Lys-118 (Lys-106) hydrogen bonds with the
carbonyl of Asp-247, the equivalent position of the terminal
carboxyl of Hsp70/90. In addition to these five canonical resi-
dues, Tyr-181 (Tyr-169), conserved across eukaryotes, forms a
hydrogen bond with the side chain of Asp-246 (Fig. 1,D and E).
The TPR Domain of Sgt2 Is a General HSC Binding Interface—
Sgt2 is physically linkedwith several families of heat-shock pro-
teins. Hsp70 homologs Ssa1 and Ssa2, Hsp110 homologs Sse1
and Sse2, the Hsp90 homolog Hsc82, and the Hsp100 homolog
Hsp104 co-purify with Sgt2 from yeast lysate, and all of these
interactions are abolished by mutation of residues in the two-
carboxylate clamp (5, 24). TPR domain containing co-chaper-
ones often have specificity for different HSCs; therefore, we
asked if Sgt2 can either bind each of these chaperone families
directly or if co-immunoprecipitation of certain families were
mediated by sub-complexes between chaperones. For example,
Sse1 can form a stable complex with Ssa1 (44). SGT and a hom-
olog fromC. elegans can bind directly to either Hsp70 or Hsp90
(11–13). Using a nickel affinity pulldown assay, purified Ssa1
and Hsc82 bind directly to a polyhistidine-tagged TPR domain
of Sgt2 (Fig. 2A, lanes 1–2 and 4–5). A triple mutant of the
Sgt2-specific Y169F and the two-carboxylate clamp residues
R171A and R175A (designated “FAA” corresponding to AfSgt2
numbering Y181/K183/R187 (Fig. 1, D and E)), reduced bind-
ing to background levels (Fig. 2A, lanes 3 and 6). Hsp104 has a
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C-terminal sequence of MEIDDDLD and binds to the two-car-
boxylate clamp in Cpr7 and the TPR1 domain of Sti1 (45). The
C-terminal sequence of Sse1 is more divergent with the
sequence EGDVDMD. Both Sse1 and Hsp104 bind to the TPR
domain of Sgt2 dependent on the two-carboxylate clamp (Fig.
2A, lanes 7–12).
The structural basis for TPR domain specificity has beenwell
characterized in HOP/Sti1. The TPR1 domain of HOP/Sti1
binds Hsp70 and Hsp100, whereas the TPR2A domain binds
Hsp90 (27, 45). The identity of the hydrophobic residues pre-
ceding the EEVD terminus of Hsp70 and Hsp90 is critical for
specific binding (46). Structure-guided mutational analysis
determined a set of TPR residues that impact specificity, in
particular TPR residues equivalent to positions Met-125 (Met-
113), Ser-159 (Ser-147), and Ala-160 (Ser-148) in AfSgt2 (Figs.
1E and 2B) (43). In HOP-TPR1, these positions are occupied by
Leu-15, Ala-49, and Lys-50, and the isoleucine of the Hsp70
GPTIEEVD sequence fits between the alanine and lysine side
chains on 3 (Fig. 2C). Alternatively, in HOP-TPR2a, the
respective positions are occupied by Tyr-236, Phe-270, and
Glu-271, and themethionine of the Hsp90MEEVD sequence is
found between 3 and 1 interacting with the tyrosine and
glutamate (Fig. 2D). A structure of HOP-TPR2a bound with
non-cognate Hsp70-derived peptide shows that the isoleucine
is not accommodated and becomes solvent-exposed (47). In
contrast with the HOP/Sti1 TPR domains, these positions in
Sgt2 create an open pocket that we predict accommodates a
wider range of substrates (Fig. 2B). Met-125 (Met-113) is con-
served across the eukaryotic kingdom; Ser-159 (Ser-147) and
Ala-160 (Ser-148) are highly conserved in fungi (Fig. 1E).
FIGURE 1. Crystal structure ofAfSgt2 TPR domain. A, the asymmetric unit shown as a ribbons diagramwith color ramped from the N (blue) to C (red) termini.
The region in gray is a cloning artifact. The crystallographic dimer is inset. B, AfSgt2-TPR as in A superposed on human SGTA TPR domain (gray, PDBID 2VYI).
C, superposition of AfSgt2 and bound C-terminal linker (rainbow,magenta carbons) onto Hsc70 peptide-bound HOP TPR1A (gray, cyan carbons, PDBID 1ELW).
D, AfSgt2 TPR groove with a 1 2Fo  Fc simulated annealing omit map of the C-terminal linker of AfSgt2 (gray carbons). Hydrogen bonds to conserved
two-carboxylate clamp residues (magenta carbons) are indicatedasblackdashes. Residues are labeledbasedon theAfSgt2 sequence. Sgt2-specific residues are
shownas cyan carbons. TheFAAmutantpositions areunderlined. E, alignmentof the sequenceobserved in the crystal structure. Sequences are:Af,A. fumigatus;
Sc,S. cerevisiae;Ce,C. elegans;Hs,Homosapiens;T1,H. sapiensHOPTPR1;T2,H. sapiensHOPTPR2a. Thenumberingabove is fromA. fumigatus. Residuespredicted
to be involved in substrate specificity are marked with asterisks. The locations of the FAA mutations are indicated with arrowheads. Two-carboxylate clamp
residues and conserved Sgt2 residues are highlighted inmagenta and cyan, respectively. Further TPR conserved residues are highlighted in red. The C-terminal
linker bound in the TPR groove is highlighted in gray.
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Higher eukaryotes have a conserved basic residue at position
160, perhaps indicating variation in specificity. Additionally,
Ala-155 (Ala-143), Ala-156 (Ala-144), and Ala-157 (Ala-145)
are strictly conserved in Sgt2 and complete the substrate inter-
acting face of 3 (Figs. 1E and 2B).
Another characterized example of binding to multiple heat-
shock protein families is the C-terminal TPR domain of Hsp70
interacting protein, CHIP, which can bind either Hsp70 or
Hsp90. Structures with peptides derived from either chaperone
show that, rather than binding in an extended conformation,
the bound peptide kinks immediately prior to the EEVD motif
to position the upstream isoleucine or methionine into a large
hydrophobic pocket lined by 5, 6, and 7 that is unique to
CHIP (29, 48).
The Sgt2 Dimer Binds a Single Copy of Get5 at a Canonical
Ubl Interface—Yeast two-hybrid assays (7, 14) and analytical
SEC (5) indicated that the N terminus of Sgt2 and the Ubl
domain of Get5 are necessary for binding between these two
proteins; however, molecular details of this interaction remain
to be defined. We used a nickel affinity pulldown assay to fur-
ther characterize the complex. Residue ranges of the domains
of Sgt2 and Get5 are defined in Fig. 3A. Polyhistidine-tagged
Get4/Get5 can bind Sgt2 (Fig. 3B, lane 2), as well as Get4/
Get5C (Fig. 3B, lane 3), indicating that dimerization of Get4/
Get5 is not essential for the interaction. Further deletion of the
Ubl domain abolishes binding to Sgt2 (Fig. 3B, lane 4). We
previously identified a double mutant of Get5, L120A/K124A,
that resulted in incomplete rescue of a Get5 deletion strain and
is predicted to disrupt a conserved binding interface in ubiqui-
tin-like domains (6, 49). Get4/Get5-L120A/K124A is unable to
bind Sgt2 (Fig. 3C, lane 5). In the absence of Get4, recombinant
Get5 is unstable and prone to forming inclusion bodies or sus-
ceptible to proteolysis (5, 6, 14). Removing theN-terminal Get4
binding domain results in a stable Get5-Ubl-C (6), which is
capable of binding to Sgt2 (Fig. 3C, lane 6). We generated a
construct of the N-terminal 72 residues of Sgt2. This minimal
domain alone was sufficient to bind to Get4/Get5 (supplemen-
tal Fig. S2A). From this assay, we conclude that the interaction
betweenGet4/Get5 and Sgt2 is predominantly between theUbl
domain of Get5, and the N-terminal domain of Sgt2 and is
mediated by a canonical binding interface.
We next investigated the stoichiometry of the interaction
between Sgt2 andGet5. After formation, complexes of Sgt2 and
Get5 are stable and can be purified from unbound protein by
SEC (supplemental Fig. S3). Purified complexes are stable upon
further SEC and were subjected to SEC coupled with MALLS
for molecular weight determination (Fig. 3C and Table 1). The
Sgt2-N dimer possibly has two unique binding interfaces;
therefore, up to two copies of Get5-Ubl might be expected to
bind. However, only a single higher weight peak was observed
after incubation with a 3-fold stoichiometric excess of Get5-
Ubl (supplemental Fig. S3). The MALLS molecular weight of
this complex was most consistent with an Sgt2-N dimer and a
single copy of Get5-Ubl (Fig. 3C, top, and Table 1). Similarly,
FIGURE 2. Sgt2 bindsmultiple chaperone families. A, SDS-PAGE of nickel affinity pulldown assays of Ssa1, Hsc82, Sse1, or Hsp104 in the absence of Sgt2 (),
with wild-type polyhistidine-tagged Sgt2-TPR (WT) or polyhistidine-tagged Sgt2-TPR-FAA (FAA). B–D, hydrophobic binding pocket on the TPR groove (cyan)
with bound peptides (magenta) of AfSgt2-TPRwith symmetrymolecule (B),H. sapiensHOP TPR1with Hsp70-derived peptide (PDB ID 1ELW) (C), andH. sapiens
HOP TPR2A with Hsp90-derived peptide (PDBID 1ELR) (D).
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when Sgt2-N-TPR was incubated with excess Get5-Ubl the
determined molecular weight of the resulting complex was in
closer agreement with a single bound copy of Get5-Ubl than
two copies. Under the conditions tested here, we did not detect
Sgt2 binding to more than one copy of Get5.
When Get5-Ubl-C was incubated with excess Sgt2-N, the
resulting complex had a determined molecular mass of 57.88
kDa (Fig. 3C,middle). A complex of a Get5-Ubl-C dimer with a
single Sgt2-N dimer has an expected molecular mass of 49.4
kDa and also with two Sgt2-N dimers of 65.2 kDa.When Get4/
Get5 was incubated with excess Sgt2-N-TPR, the resulting
complex had a molecular mass of 186 kDa, a value closer to a
single copy of the Get4/Get5 dimer with a single copy of the
Sgt2-N-TPR dimer (Fig. 3C, bottom). Although full-length Sgt2
can interact with Get4/Get5 (Fig. 3B), the same sample by SEC
showed no higher peaks relative to each protein run individu-
ally. This could suggest a conformational change resulting in a
similar hydrodynamic radius for the complex relative to the
individual proteins; however, it is more likely that the complex
simply was not stable by this method. It is possible that steric
clashes between Get4 and the Sgt2-C domain, or increased
entropic costs, reduce the binding affinity.
Ydj1 Does Not Directly Bind the Sgt2-Get4/Get5 Complex—
The yeast DnaJ homolog Ydj1 is reported to bind Get5, which
mediates a genetic interaction between Ydj1 and Sgt2 (14). In
that study, recombinant Get5, in the absence of Get4, formed
an in vitro complex with Ydj1.We tested whether Ydj1 binds to
purified Get4/Get5 but did not see any enrichment in a pull-
down assay, nor could we detect binding with the addition of
Sgt2 or Ssa1 (supplemental Fig. S2B). The N-terminal domain
of Get5 causes the protein to aggregate in the absence of Get4,
and we propose that Ydj1 binds in response to this aggregation.
Rather than directly interacting with Sgt2, Get4, or Get5, the
genetic linkage is likely due to the role of Ydj1 in regulating
Ssa1. It is noteworthy that Sis1, the other DnaJ homolog in
yeast, co-immunoprecipitates with Sgt2 dependent upon two-
carboxylate clamp (5).
SAXS of Sgt2—Sgt2 is a multidomain dimeric protein with
an extended conformation whose domain arrangement is
unknown. Small angle x-ray scattering (SAXS) allows determi-
nation of particle size, analysis of flexibility, and ab initio deter-
mination of low resolution structure. This allows modeling of
higher order assemblies when coupled with high resolution
structures of individual domains. SAXS was performed on Sgt2
using the constructs indicated in Table 1. Values for radius of
gyration (Rg) and the maximum particle distance (Dmax) were
obtained from the indirect Fourier transform processed in
GNOM.We generated ab initiomodels of Sgt2-N and Sgt2-N-
TPR using GASBOR (50), which uses dummy residues
restrained with simulated chain connectivity to fit experimen-
tal data. A total of 20 independent models was generated for
each construct, and these were superposed, averaged, and fil-
tered using DAMAVER (51). The resulting model represents
the most probable volume shared by the individual models.
Sgt2-N was reconstructed as a somewhat spherical particle, in
agreement with the p(r) function, which has a single peak that
smoothly approaches zero (Fig. 4,A andB). The p(r) function of
Sgt2-N-TPR is indicative of multiple folded domains as it has
FIGURE 3. The Sgt2-Get4/Get5 complex. A, schematics indicating residue
ranges of domains described in text with corresponding letter abbreviations.
B, SDS-PAGEof nickel affinity pulldownassays. Get4 andGet5 are abbreviated
as 4 and 5, respectively, with “h” indicating the polyhistidine-tagged protein.
C, SEC-MALLS of Sgt2 and Get4/Get5 complexes. Traces are normalized to
maximum differential refractive index. Horizontal lines are experimentally
measuredmolecularweight (right axis). Proteins added in 3-fold stoichiomet-
ric excess to generate complexes are Get5-Ubl (top), Sgt2-N (middle), Sgt2-N-
TPR (bottom).
TABLE 1








Sgt2-NDimer 15.8 14.66 16.9 65






Get5-Ubl/Sgt2-N 25.7, 35.7b 23.78 20.7 70
Get5-Ubl/Sgt2-N-TPR 59.1, 69.1 52.19
Sgt2-N/Get5-Ubl-C 49.4, 65.2 57.88
Sgt2-N-TPR/Get4/Get5 169.1, 218.2 186.2
a Values are the average for a 50-model ensemble selected by EOM (54).
b The molecular mass was estimated from sequences for 1:1 and 2:1 ratios.
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more than one peak (Fig. 4C). Sgt2-N-TPR reconstructed as a
curved tubular shape, with two volumes, appropriately sized for
TPR domains, extending out from the dimerization domain in
the same plane (Fig. 4D).We additionallymodeled Sgt2-N-TPR
with the program BUNCH, which allows fitting to multiple
SAXS curves in cases where scattering from truncations are
available, and it also fits high resolution structures as rigid bod-
ies (52). In this case, the fit utilized the TPR crystal structure
and Sgt2-N curve in addition to the Sgt2-N-TPR curve.
Unknown regions were generated ab initio as dummy residues.
The resulting models are in agreement with the averaged GAS-
BOR model (Fig. 4E). The orientation of the TPR domain
groove is not resolved by SAXS; it may be resolution-limited or
averaged due to flexibility in the inter-domain linker. Impor-
tantly, the angle formed between the TPR domains and the
N-domain, as well as the end-to-end distance of the TPR
domains is consistent between models frommultiple methods.
From primary sequence, Sgt2-TPR-C is expected to have
high flexibility, and the shape of the Kratky plot is characteristic
of a partially folded protein as intensity plateaus to a non-zero
value as Q increases (53) (Fig. 5A). The program EOM inter-
prets SAXS data of flexible proteins by selecting ensembles of
structures to fit scattering from a large, diverse pool of struc-
tures (54). The AfSgt2-TPR crystal structure was linked with
10,000 random C models of the C-terminal domain. An
ensemble of 50 structures was fit to the data (Fig. 5B). The Rg
and Dmax distributions (Fig. 5, C and D) of the fitted structures
have similar center and shape to the entire random pool of
structures, indicating unrestricted flexibility between the TPR
and C-terminal domains.
We further used SAXS to confirm the stoichiometry between
Sgt2 and Get5. Using data for the purified Sgt2-N/Get5-Ubl
complex, the molecular envelope was reconstructed with the
program DAMMIF (Fig. 6, A and B). DAMMIF uses dummy
atoms to fill a volume that satisfies the SAXS curve and, unlike
GASBOR, does not require total residue number as an input,
reducing bias of the complex stoichiometry. The averaged
model is ellipsoidal, with a long dimension of60 Å. This can
only be fit with the 40-Å diameter reconstruction of the Sgt2-N
dimer (Fig. 4B) and a single Get5-Ubl of20-Å diameter, pre-
viously modeled from an NMR structure (Fig. 6C) (6).
DISCUSSION
The mechanism for the sorting of TA proteins among the
variety of targetmembranes is only beginning to be understood.
FIGURE 4. SAXS of Sgt2-N and Sgt2-N-TPR. A and C, experimental SAXS curve (black), fits of the best GASBOR (red) and BUNCH (blue) models and pair-
probability functions (inset) for Sgt2-N (A) and Sgt2-N-TPR (C). B and D, ab initio reconstructions of 20 averaged and filtered GASBORmodels of Sgt2-N (B) and
Sgt2-N-TPR (D). Bottom images are rotated relative to top images. E, four example BUNCH models. Blue regions were fit to both Sgt2-N and Sgt2-N-TPR data,
while red regionswere fit to only Sgt2-N-TPR.
FIGURE 5. SAXS of the flexible Sgt2-TPR-C. A, Kratky plot; B, experimental
SAXS curve of Sgt2-TPR-C (black) with EOM fit (red); C and D, Rg and Dmax
distributions, respectively, for 10,000 random C-domain models relative to
the TPR domain (dashed lines) versus 50models fit to experimental data (solid
lines). Correlation suggests unrestricted motion of the C-domain relative to
the TPR domain.
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Sgt2 appears to selectively bind ER-destined TA proteins trans-
ferring these substrates with the aid of Get4/Get5 to Get3. Sgt2
contains a TPR domain that physically links the GET pathway
to other chaperone pathways. Although other characterized
TPR domain-containing co-chaperones are limited in their
binding to one or two heat-shock protein families, we demon-
strate here that the Sgt2 TPR domain can bind directly tomem-
bers of at least four families. This promiscuity is explained by
the structure of the Sgt2 TPR domain. A phylogenetic analysis
of TPR domain sequences indicated that the Sgt2 TPR domain
is most similar to the HOP domains (55) and, indeed, in our
structure, bound peptide adopts an identical conformation.
The determinants of substrate specificity include the conserved
binding pocket formed by residues Met-125 (Met-113), Ala-
155 (Ala-143), Ala-156 (Ala-144), Ala-157 (Ala-145), Ser-159
(Ser-147), andAla-160 (Ser-148). This wider pocket is sterically
less restrictive than the HOP TPR domains presumably allow-
ing for the binding of non-canonical two-carboxylate clamp
substrates such as the EGDVDMD of Sse1. Moreover, human
SGTA TPR can interact with an internal stretch in the andro-
gen receptor that does not contain a clear binding motif sug-
gesting an even broader specificity (56). In addition to the five
two-carboxylate clamp residues, a conserved tyrosine contrib-
utes a hydrogen bond to the side chain of the residue corre-
sponding to the terminal residue in Hsp70 or Hsp90. It is pos-
sible that this further stabilizes binding to longer sequences.
Is it simply fortuitous that the linker following the AfSgt2
TPR contains the sequence PPADDVDD, resembling an HSC
termini? Evidence for a possible functional role is that the
sequence is conserved in the Eurotiomycetes family, ofwhichA.
fumigatus is a member, and S. cerevisiae Sgt2 contains the
related sequence SRDADVDA (Fig. 1E). Unfortunately, similar
regions are not found more broadly in other fungal homologs,
and there are no comparable sequences found in higher
eukaryotes. This does not rule out family-specific specializa-
tion, perhaps binding other co-chaperones; however, it makes a
general conserved role for this sequence unlikely.
Sgt2 forms a direct complex with Get4/Get5mediated by the
dimerization domain of Sgt2 and the Ubl domain of Get5.
Despite possible symmetry of Sgt2-N, only a single copy of
Get5-Ubl can bind with high affinity. The Vps9-CUE domain is
a homo-dimeric -helical domain that binds ubiquitin at its
symmetry axis and undergoes a conformational change that
breaks symmetry to resemble a ubiquitin-associating domain
(57). The Sgt2/Get5 complex may undergo similar rearrange-
ments. Alternatively, binding of one copymay simply occlude a
second binding site. The inability of Sgt2 to bind a second Ubl
domain creates a potential for the Get4/Get5 dimer to bind two
dimers of Sgt2. In vitro, complexes between the minimal bind-
ing domains are stable indefinitely; however, as additional
domains are included only a single dimer of Sgt2 can bindGet4/
Get5, and the full-length proteins do not form a complex stable
over SEC. This leaves the overall in vivo stoichiometry ambig-
uous. It is likely that other factors, such as the Get4 to Get3
interaction, may result in a dynamic complex.
Based on the data we present here we can suggest an updated
model for the role of Sgt2 in TA targeting and an overall struc-
ture of the Sgt2/Get4/Get5/HSC complex (Fig. 7). The SAXS
analysis of Sgt2-N-TPR suggests that the TPR domains have
independentmotion.Coupledwith the observations thatN-do-
main deletions still bind both HSC and TA proteins (5), we
conclude that the two Sgt2-TPR-C domains act independently.
This would allow for the Sgt2 dimer to bind multiple HSCs
simultaneously. The dimerization domain of Sgt2 would bind
one Ubl of the Get4/Get5 hetero-tetramer. Sgt2 will sequester
an ER-bound TA and deliver it specifically to Get3.
Thiswork allows us to speculate on the interplay ofHSCs and
theGET pathway. The low specificity for HSC families suggests
that Sgt2 can interact with unfolded proteins distributed
among themajority of protein folding pathways in the cell. This
may allow Sgt2 to act as a general recovery pathway for TA
FIGURE 6. SAXS of an Sgt2/Get5 complex. A, experimental SAXS curve
(black) versus fit of the best DAMMIF model (red). The pair-probability func-
tion of Sgt2-N/Get5-U is inset. B, filtered average of 20 DAMMIF models.
C, filtered average GASBOR model of Sgt2-N (blue spheres) and space filling
model of a homology model of Get5-Ubl (green) fit into the filtered average
model of Sgt2-N/Get5-Ubl (orange mesh).
FIGURE 7. Model for the Sgt2/Get4/Get5/HSC complex. Sgt2 (purple) is
bound to Get4/Get5 via the Ubl domain (green). TA protein (red) transmem-
brane domainmay initially be in complex with an HSC (e.g.with Ssa1, yellow)
with subsequent binding to the Sgt2-TPR and transfer to Sgt2-C. Alterna-
tively, the transmembrane domain initially binds to Sgt2-C and chaperones
required for substrate stabilization are bound to the Sgt2-TPR. The complex
then releases the TA protein to Get3.
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proteins through its TPR domain, consistent with a recent
observation that the TPR domain is not essential for targeting
of certain substrates by Get3 under low stress conditions (58).
Perhapsmore prominently, given the genetic role of Sgt2 in the
GET pathway, Sgt2 uses the TPR domain to couple multiple
folding pathways with TA targeting. This would allow TA sub-
strateswith a variety of folding needs to enter theGETpathway.
Combined, this suggests two possible routes for TA proteins
through Sgt2: either HSCs bind the TA protein first and deliver
them to Sgt2, or Sgt2 binds the TA first and chaperones are
recruited to either aid in folding or to act as acceptors if the TA
protein is not ER-destined.
TA proteins are diverse with the majority specifically tar-
geted to either the ER or mitochondria. For those destined to
the ER, both the GET pathway and Hsp70 operate post-trans-
lational targeting pathways, the former being critical as TA
hydrophobicity increases (59). Targeting of TA proteins to the
mitochondria is less characterized. It has been suggested that
this may only depend on Hsp70/90-mediated targeting to the
co-chaperoneTPR receptors on themitochondria (60, 61). This
type of targeting could be more general as co-chaperone TPR
receptors exist on every organelle (55, 62). These overlapping or
alternative pathways may allow delivery independent of the
GET pathway, possibly explaining why none of the individual
GET components are essential under optimal conditions. All of
this would suggest an important role for co-chaperone TPR
proteins in delivery of TA proteins. Sgt2 would be the central
co-chaperone acting as a sortase to optimize correct delivery to
the GET pathway. If so, TA targeting by Sgt2 may be more akin
to panning for gold, retaining substrate proteins for entry to the
GET pathway from different points in protein biogenesis.
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